Latest Breaking News On - Noble bioscience corp - Page 1 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp. and Its Agency Rights . Medivolve Inc.February 2, 2021 GMT Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that converts into a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a webinar Thursday, February 4 th at 1 pm ET. TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) has entered into an agreement to acquire 100% of Noble Bioscience Corp. (“Noble Bioscience”) in exchange for 12.5 million common shares of Medivolve. Noble Bioscience holds the agency rights to Nuturell’s Surface Shield technology in the United States, Canada and Caribbean countries. Medivolve’s subsidiary Collection Sites, LLC will lead

United statesSan diegoVeronica welchLawrence steinmanEvan veryardTim shelburnLas vegasDoug sommervilleGlenn copelandNuturell surface shield technologyCollection sitesMedivolve incStock exchangeMarvel diagnostics incNoble bioscience corpAnalysis services